Treace Medical Concepts, Inc. Investing Cash Flow
Treace Medical Concepts, Inc. (TMCI) reported Investing Cash Flow of -$748.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $7.07M.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$7.82M.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $9.67M, a 182.55% increase year-over-year.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $8.74M, a 51.59% increase year-over-year.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $13.25M, a 62.54% decline from fiscal 2024.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $35.38M.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$81.30M.
- Treace Medical Concepts, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$76.52M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$748.00K 10-Q · filed 2026-08-07 | $8.92M derived: sum of 3 quarters · filed 2026-08-07 | $17.65M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$7.82M 10-Q · filed 2026-05-08 | $1.85M derived: sum of 2 quarters · filed 2026-05-08 | $10.59M derived: sum of 3 quarters · filed 2026-05-08 | $7.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.40M derived: sum of 2 quarters · filed 2026-02-27 | $15.14M derived: sum of 3 quarters · filed 2026-08-07 | $13.25M 10-K · filed 2026-02-27 |
| 2025-09-30 | $8.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.48M derived: sum of 2 quarters · filed 2026-08-07 | $3.58M 10-Q · filed 2025-11-06 | $7.01M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$5.15M 10-Q · filed 2026-08-07 | -$1.73M derived: sum of 3 quarters · filed 2026-08-07 | $4.03M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$1.89M 10-Q · filed 2026-05-08 | $1.53M derived: sum of 2 quarters · filed 2026-05-08 | $7.29M derived: sum of 3 quarters · filed 2026-05-08 | $29.72M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.18M derived: sum of 2 quarters · filed 2026-02-27 | $31.62M derived: sum of 3 quarters · filed 2026-02-27 | $35.38M 10-K · filed 2026-02-27 |
| 2024-09-30 | $5.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $28.20M derived: sum of 2 quarters · filed 2025-11-06 | $31.95M 10-Q · filed 2025-11-06 | $36.96M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $22.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $26.19M 10-Q · filed 2025-08-07 | $31.20M derived: sum of 3 quarters · filed 2026-02-27 | $35.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $3.76M 10-Q · filed 2025-05-08 | $8.77M derived: sum of 2 quarters · filed 2026-02-27 | $13.36M derived: sum of 3 quarters · filed 2026-02-27 | $2.94M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.60M derived: sum of 2 quarters · filed 2026-02-27 | -$819.00K derived: sum of 3 quarters · filed 2026-02-27 | -$81.30M 10-K · filed 2026-02-27 |
| 2023-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$5.83M derived: sum of 2 quarters · filed 2024-11-05 | -$86.31M 10-Q · filed 2024-11-05 | -$150.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$10.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$90.90M 10-Q · filed 2024-08-06 | -$154.91M derived: sum of 3 quarters · filed 2025-02-27 | -$160.77M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$80.48M 10-Q · filed 2024-05-07 | -$144.49M derived: sum of 2 quarters · filed 2025-02-27 | -$150.35M derived: sum of 3 quarters · filed 2025-02-27 | -$155.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$64.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$69.87M derived: sum of 2 quarters · filed 2025-02-27 | -$75.04M derived: sum of 3 quarters · filed 2025-02-27 | -$76.52M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$11.03M derived: sum of 2 quarters · filed 2023-11-09 | -$12.51M 10-Q · filed 2023-11-09 | -$13.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$6.65M 10-Q · filed 2023-08-09 | -$7.55M derived: sum of 3 quarters · filed 2024-02-27 | -$8.49M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$1.48M 10-Q · filed 2023-05-09 | -$2.38M derived: sum of 2 quarters · filed 2024-02-27 | -$3.32M derived: sum of 3 quarters · filed 2024-02-27 | -$3.99M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.84M derived: sum of 2 quarters · filed 2024-02-27 | -$2.51M derived: sum of 3 quarters · filed 2024-02-27 | -$2.71M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$939.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.61M derived: sum of 2 quarters · filed 2022-11-09 | -$1.80M 10-Q · filed 2022-11-09 | -$1.89M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | -$670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$866.00K 10-Q · filed 2022-08-10 | -$954.00K derived: sum of 3 quarters · filed 2023-03-08 | -$1.01M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$196.00K 10-Q · filed 2022-05-06 | -$284.00K derived: sum of 2 quarters · filed 2023-03-08 | -$342.00K derived: sum of 3 quarters · filed 2023-03-08 | -$591.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$146.00K derived: sum of 2 quarters · filed 2023-03-08 | -$395.00K derived: sum of 3 quarters · filed 2023-03-08 | -$1.07M 10-K · filed 2023-03-08 |
| 2020-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$307.00K derived: sum of 2 quarters · filed 2021-11-04 | -$981.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$923.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$674.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | -$1.21M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |